publication venue for
- Validation of Available Extended-Spectrum-Beta-Lactamase Clinical Scoring Models in Predicting Drug Resistance in Patients with Enteric Gram-Negative Bacteremia Treated at South Texas Veterans Health Care System.. 65. 2021
- Structure-Activity Relationship Analysis of Benzotriazine Analogues as HIV-1 Latency-Reversing Agents.. 64. 2020
- Mycobacterium tuberculosis. 63. 2019
- Synthetic Ingenols Maximize Protein Kinase C-Induced HIV-1 Latency Reversal.. 62. 2018
- SLCO1B1. 62. 2018
- Transmission of Resistant Gram-Negative Bacteria to Health Care Worker Gowns and Gloves during Care of Nursing Home Residents in Veterans Affairs Community Living Centers.. 61. 2017
- Ex Vivo Bioactivity and HIV-1 Latency Reversal by Ingenol Dibenzoate and Panobinostat in Resting CD4(+) T Cells from Aviremic Patients.. 59:5984-91. 2015
- Comparative effectiveness of aminoglycosides, polymyxin B, and tigecycline for clearance of carbapenem-resistant Klebsiella pneumoniae from urine.. 55:5893-9. 2011
- Tigecycline exhibits inhibitory activity against Clostridium difficile in the colon of mice and does not promote growth or toxin production.. 55:546-9. 2010
- Targeted surveillance of methicillin-resistant Staphylococcus aureus and its potential use to guide empiric antibiotic therapy.. 54:3143-8. 2010
- Peptide nucleic acid fluorescent in situ hybridization for hospital-acquired enterococcal bacteremia: delivering earlier effective antimicrobial therapy.. 52:3558-63. 2008
- Vegetative Clostridium difficile survives in room air on moist surfaces and in gastric contents with reduced acidity: a potential mechanism to explain the association between proton pump inhibitors and C. difficile-associated diarrhea?. 51:2883-7. 2007
- In vitro killing of nosocomial pathogens by acid and acidified nitrite.. 50:3901-4. 2006
- Suppression of gastric acid production by proton pump inhibitor treatment facilitates colonization of the large intestine by vancomycin-resistant Enterococcus spp. and Klebsiella pneumoniae in clindamycin-treated mice.. 50:3905-7. 2006
- Epidemiological risk factors for isolation of ceftriaxone-resistant versus -susceptible citrobacter freundii in hospitalized patients.. 47:2882-7. 2003
- Risk factors for piperacillin-tazobactam-resistant Pseudomonas aeruginosa among hospitalized patients.. 46:854-8. 2002